- Home
- STEC vs RADX Comparison
STEC vs RADX Comparison
Compare STEC & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEC
- RADX
- Stock Information
- Founded
- STEC 2006
- RADX 2021
- Country
- STEC Hong Kong
- RADX Australia
- Employees
- STEC N/A
- RADX N/A
- Industry
- STEC
- RADX
- Sector
- STEC
- RADX
- Exchange
- STEC NYSE
- RADX NYSE
- Market Cap
- STEC 29.7M
- RADX 32.5M
- IPO Year
- STEC 2021
- RADX N/A
- Fundamental
- Price
- STEC $0.73
- RADX $4.20
- Analyst Decision
- STEC
- RADX Strong Buy
- Analyst Count
- STEC 0
- RADX 2
- Target Price
- STEC N/A
- RADX $13.50
- AVG Volume (30 Days)
- STEC 12.9K
- RADX 17.8K
- Earning Date
- STEC 07-22-2025
- RADX 02-26-2025
- Dividend Yield
- STEC N/A
- RADX N/A
- EPS Growth
- STEC N/A
- RADX N/A
- EPS
- STEC N/A
- RADX N/A
- Revenue
- STEC $10,672,000.00
- RADX $204,609.00
- Revenue This Year
- STEC $9,392.20
- RADX N/A
- Revenue Next Year
- STEC N/A
- RADX N/A
- P/E Ratio
- STEC N/A
- RADX N/A
- Revenue Growth
- STEC N/A
- RADX N/A
- 52 Week Low
- STEC $0.20
- RADX $3.50
- 52 Week High
- STEC $3.25
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- STEC 32.63
- RADX N/A
- Support Level
- STEC $0.81
- RADX N/A
- Resistance Level
- STEC $0.88
- RADX N/A
- Average True Range (ATR)
- STEC 0.07
- RADX 0.00
- MACD
- STEC -0.01
- RADX 0.00
- Stochastic Oscillator
- STEC 35.80
- RADX 0.00
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.